The global veterinary pain management drugs market is anticipated to grow at a CAGR of 3.8% during the forecast period. Veterinary pain management drugs assist in preventing and treating animals against disease. These drugs alleviate the suffering of the animal, boost health productivity, and ensure fewer animals are lost to the disease. Some of the factors propelling the growth of the global veterinary pain management drugs market include the high prevalence of inflammatory and painful diseases amongst all animals and the rising government initiatives toward animal health concerns. Moreover, rising pet ownership and innovation in vaccines and diagnosis are also crucial factors driving the global veterinary pain management drugs market. According to the National Pet Owners Survey (2022) conducted by the American Pet Products Association (APPA), pet ownership in the US household increased from 56% in 1988 to 70% (90.5 million families) in 2021.
In addition, the growth in pet insurance and investment by government authorities in livestock healthcare to increase agriculture production are creating significant scope for market development and offering new opportunities to market players. In December 2021, the Asian Development Bank (ADB) has signed an agreement to take a stake in Zenex Animal Health India Pvt. Ltd. (Zenex) with an investment of up to $10 million, to increase Zenex’s production and distribution of quality animal health care products and help boost farmer incomes by mitigating livestock disease risk. ADB will also provide a $575,000 technical assistance (TA) grant to support Zenex’s training of 2,300 farmers and 580 veterinarians in Bangladesh, India, Nepal, and Sri Lanka to tackle the major public health issue of antimicrobial resistance.
Segmental Outlook
The global veterinary pain management drugs market is segmented based on type, animal type, application, and distribution channel. Based on type, the market is sub-segmented into NSAIDs, agonists, anesthetics, opioids, DMOAD, and others. Among these types, the opioids segment holds the considerable growth in the market due to the added benefits of drugs in pain management. Opioids are a diverse group of naturally occurring and synthetic drugs used primarily for their analgesic activity. Opioids are the most effective analgesics available for the systemic treatment of acute pain in many species, particularly dogs and cats. Due to increasing inflammatory and painful diseases among animals, the demand for opioids drug is expected to increase more during the forecast period, thereby creating significant scope for segment growth. Based on animal type, the market is bifurcated into companion animals and livestock animals. Based on application, the market is sub-segmented into osteoarthritis, musculoskeletal disorders, cancer, and others. Whereas based on distribution channels, the market is further categorized into veterinary hospitals, veterinary clinics, and others.
Regional Outlook
Geographically, the global veterinary pain management drugs market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Among these, the Asia-Pacific region is estimated to grow at the fastest CAGR in the veterinary pain management market during the forecast period. Major economies such as China, India, and Japan are contributing significant shares and offering new growth opportunities for market players due to the presence of a huge livestock population. Moreover, rising pet ownership along with high investment in animal healthcare is also the prominent factor leading to the high demand for global veterinary pain management drugs, which in turn, boosts the overall market growth.
Global Veterinary Pain Management Drugs Market Growth By Region, 2022-2028
North America Holds the Largest Share in Veterinary Pain Management Drugs Market
Geographically, the North American region held the highest market share in 2021. The region is estimated to dominate by accounting for a significant share in upcoming years. In North America, the US is expected to hold the largest share due to greater awareness regarding animal health, rising R&D activities for the development of new veterinary pain management drugs and therapeutics and increasing animal health insurance for drugs and other products. The strong presence of big players in the market and new drug development by them in collaboration with other players is further projected to expand the regional market on a wider level. For instance, in January 2022, Boehringer Ingelheim entered into a collaboration with MabGenesis, a private biopharmaceutical company to discover and develop novel monoclonal antibodies for potential canine treatments. The collaboration will lead to the discovery of innovative canine therapeutic antibodies bringing benefits to animal health.
Market Players Outlook
The major market players in the global veterinary pain management drugs market include Zoetis Inc., Merck & Co., Inc., BASF SE, Bayer AG, Boehringer Ingelheim International GmbH, Cargill Inc., Elanco Animal Health Inc., and Eli Lilly and Co., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.
The Report Covers
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Zoetis Inc.
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. Merck & Co., Inc.
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. BASF SE
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Veterinary Pain Management Drugs Market by Type
4.1.1. NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
4.1.2. Agonists
4.1.3. Anesthetics
4.1.4. Opioids
4.1.5. DMOADs (Disease-Modifying Osteoarthritis Drug)
4.1.6. Others
4.2. Global Veterinary Pain Management Drugs Market by Animal Type
4.2.1. Companion Animal
4.2.2. Livestock Animal
4.3. Global Veterinary Pain Management Drugs Market by Application
4.3.1. Osteoarthritis
4.3.2. Musculoskeletal Disorders
4.3.3. Cancer
4.3.4. Others
4.4. Global Veterinary Pain Management Drugs Market by Distribution Channel
4.4.1. Veterinary Hospitals
4.4.2. Veterinary Clinics
4.4.3. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East & Africa
6. Company Profiles
6.1. Assisi Animal Health
6.2. Bayer AG
6.3. Boehringer Ingelheim International GmbH
6.4. Cargill Inc.
6.5. Ceva Sante Animale
6.6. Chanelle Pharma
6.7. Dechra Pharmaceuticals
6.8. Elanco Animal Health Inc.
6.9. Eli Lilly and Co.
6.10. Evonik Industries AG
6.11. Idexx Laboratories Inc.
6.12. Kemin Industries, Inc
6.13. Norbrook Laboratories Ltd.
6.14. Sumitomo Chemical Co. Ltd.
6.15. Vetoquinol S.A
1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL NSAIDS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL AGONISTS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL ANESTHETICS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL OPIOIDS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL DMOADS VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL OTHER VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
9. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS FOR COMPANION ANIMALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS FOR LIVESTOCK ANIMALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
12. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OSTEOARTHRITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN MUSCULOSKELETAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
17. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN VETERINARY HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN VETERINARY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
19. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OTHER DISTRIBUTION CHANNELS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
21. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
23. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
24. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
25. NORTH AMERICAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
26. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
28. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
29. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
30. EUROPEAN VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
31. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
32. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
33. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
34. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
35. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
36. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
37. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
38. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
39. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
40. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
1. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
2. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY ANIMAL TYPE, 2021 VS 2028 (%)
3. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
4. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
6. GLOBAL NSAIDS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
7. GLOBAL AGONISTS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. GLOBAL ANESTHETICS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
9. GLOBAL OPIOIDS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
10. GLOBAL DMOADS VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
11. GLOBAL OTHER VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
12. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS FOR COMPANION ANIMALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
13. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS FOR LIVESTOCK ANIMALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
14. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OSTEOARTHRITIS MARKET SHARE BY REGION, 2021 VS 2028 (%)
15. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN MUSCULOSKELETAL DISORDERS MARKET SHARE BY REGION, 2021 VS 2028 (%)
16. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN CANCER MARKET SHARE BY REGION, 2021 VS 2028 (%)
17. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OTHER APPLICATIONS MARKET SHARE BY REGION, 2021 VS 2028 (%)
18. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN VETERINARY HOSPITALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
19. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
20. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS IN OTHER DISTRIBUTION CHANNELS MARKET SHARE BY REGION, 2021 VS 2028 (%)
21. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
22. US VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
23. CANADA VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
24. UK VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
25. FRANCE VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
26. GERMANY VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
27. ITALY VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
28. SPAIN VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF EUROPE VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
30. INDIA VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
31. CHINA VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
32. JAPAN VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
33. SOUTH KOREA VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
34. REST OF ASIA-PACIFIC VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
35. REST OF THE WORLD VETERINARY PAIN MANAGEMENT DRUGS MARKET SIZE, 2021-2028 ($ MILLION)